Pricing Log in Create free account
Saturday 17 October 2026 Export DGX’s income statement to Excel — free account

Quest Diagnostics Incorporated

DGX Healthcare Diagnostics & Research

Quest Diagnostics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $11.0 billion, up 11.8% from fiscal 2024. In the quarter to June 2026, revenue grew 10.2%, EPS grew 14.7%, free cash flow grew 5.28% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

235.00 4.15 −1.74%
Market cap
$26.4B
P/E
24.6×
Fwd P/E
20.8×
Dividend yield
1.44%
F-score
8/9
Altman Z
3.15
Beneish M
−2.65
Dividend safety
85/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Quest Diagnostics Incorporated (DGX) EBITDA

Alert me on EBITDA

Quest Diagnostics Incorporated's EBITDA for fiscal 2025 was $2.1B, up 15.6% from $1.8B in fiscal 2024. Over the twelve months to 30 June 2026 it was $2.2B. Over the past ten years it has ranged from $1.4B (fiscal 2018) to $2.8B (fiscal 2021); the current reading is higher than 82% of that period. Quest Diagnostics Incorporated ranks 4th of 52 Diagnostics & Research companies by EBITDA.

EBITDA, annual

Embed this chart

Annual newest first

Period EBITDA Change
FY2025 $2.1B 15.61%
FY2024 $1.8B 8.11%
FY2023 $1.7B (8.79%)
FY2022 $1.9B (33.13%)
FY2021 $2.8B 19.60%
FY2020 $2.3B 49.49%
FY2019 $1.6B 10.64%
FY2018 $1.4B (1.74%)
FY2017 $1.4B (5.96%)
FY2016 $1.5B (10.39%)

Quarterly newest first

Period EBITDA Change
Jun 2026 $605.0M 10.81%
Mar 2026 $546.0M 2.82%
Dec 2025 $531.0M 0.57%
Sep 2025 $528.0M (9.12%)
42 more quarters

Against its own ten years

Low $1.4B High $2.8B
Ten-year median $1.7B
Current reading's percentile 82

EBITDA against peers

Company EBITDA
DGX Quest Diagnostics Incorporated $2.2B
LH Labcorp Holdings Inc. compare $2.2B
IDXX IDEXX Laboratories, Inc. compare $1.6B
MTD Mettler-Toledo International, Inc. compare $1.3B
ILMN Illumina, Inc. compare $1.2B
WAT Waters Corporation compare $942.8M
RVTY Revvity Inc. compare $775.8M
MEDP Medpace Holdings, Inc. compare $611.2M
GH Guardant Health, Inc. compare −$444.9M

What EBITDA is

EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.

Reported line item

The full definition of EBITDA →

More on DGX